請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/7014
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 蘇和平(Su-Hou Pin) | |
dc.contributor.author | Pei-Chen Yang | en |
dc.contributor.author | 楊沛蓁 | zh_TW |
dc.date.accessioned | 2021-05-17T09:24:00Z | - |
dc.date.available | 2014-12-31 | |
dc.date.available | 2021-05-17T09:24:00Z | - |
dc.date.copyright | 2012-08-28 | |
dc.date.issued | 2012 | |
dc.date.submitted | 2012-08-20 | |
dc.identifier.citation | 林慶文,蛋之化學與利用。華香園。2000。87-92。
林興中,骨質疏鬆。台灣醫界。1995。38:34-38。 林興中,骨質疏鬆症。嘉義醫訊。1993。15:10-15。 林興中,骨質疏鬆症之最近發展。台灣醫界。1994。37(3):209-212。 姚維人,吳重慶,骨質疏鬆之成因。秀傳醫學雜誌。1994。1 (4):179-185。 洪雅萍,膠原蛋白產品的功效。科學發展。2004。380:30-35。 張天鈞,Bisphosphonate與骨質疏鬆。當代醫學。1998。25(6):447-449。 張聖善,蛋品加工學。華香園。1999。4:68-78。 Angele, P., J. Abke, R. Kujat, H. Faltermerier, D. Schumann, M. Nerlich. 2004. Influence of different collagen species on physic-chemical properities of crosslinked collagen matrices. Biomaterials, 25. 2381-2841. Aubin, J. E., L. Malaval, F. Liu, and K. Gupta. 1995. Osteoblast and chondroblast Baker, J. R. and D. A. Balch. 1962. Studies of membrane, mammilary cores and cuticle of the hen egg shell. Biochem. J. 32:352. Baylink, D. and J. Wergedal. Bone formation and resorption by osteocytes. 1997. Cellular Mechanisms for Calcium Transfer and Homeostasis (Ed. Nichols G, Wasserman R. H.) 257. Berridge, M. V. and A. S. Tan. 1993. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 303:474-482. Bowers G. N. Jr. and R. B. McComb. 2000. A continuous spectrophotometric method for measuring the activity of serum alkaline phosphatase. Clin. Chem., 12, pp.70-89. Bowers, G. N. and R. B. McComb. 1966. A continuous spectrophotometric method for measuring the activity of serum alkaline phosphatase. Clin. Chem. 12:70-89. Boyan, B. D., Z. Schwartz, L. F. Bonewald. 1989. Localization of 1,25(OH)2D3-responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG63, and MC3T3) and growth cartilage cells in culture. J Biol. Chem. 264:11879-11886. Brayboy, T. R., X. W. Chen, Y. S. Lee. 2001. The protective effects of Ginkgo biloba extract (Egb 761) against free radical damage to osteoblast-like bone cells (MC3T3-E1) and the proliferative effects of Egb 761 on these cells. Nutr Res. 21:1275-1285. Buuneli, N., G. Atilla, G. Guner, and G. Oktay. 2001. Biochemical analysis of total collagen content and collagen types I, III,IV, V and VI in gingiva of various periodontitis categories. Journal of the imternational academy of periodontology. 3(1):1-6. Cameron, J. R. and J. Sorenson. 1963. Measurement of bone mineral in vivo: and improved method. Science.142:230-232. Christenson, R. 1992. Biochemical marker of bone metabolism: an overview. Clin Biochem 30: 573-593. Chvapil, M. and L. R. Kronentahl, Van. Winkle-Jr. 1973. W, Medical and Surgical Applications of Collagen. International Review of connective tissue research. Academic press. New York. pp1-61. Coelho, M. J., A. T. Cabral, M. H. Fernandes. 2000. Human bone cell cultures in biocompatibility testing. Part I: osteoblastic differentiation of serially passaged human bone marrow cells cultured in α-MEM and in DMEM. Biomaterials. 21:1087-1094. Coelho, M. J., A. T. Carbral, and M. H. Fernandes. 2000. Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, β-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials. 21:1095-1102. Dai, J., D. Lin, J. Zhang, P. Habib, P. Smith, J. Murtha, Z. Fu, Z. Yao, Y. Qi and E. T. Keller. 2000. Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. J Clin. Invest. 106(7):887-895. Deyl, Z., I. Mikšik. 2000. Advanced sparation methods for collagen parent α-chains, their polymers and fragments. Journal of Chromatography B. 739, 3-31. differentiation. Bone. 17:77s-83s. Eriksen, E. and Kassem M. 1992. The cellular basis of bone remodeling. Triangle, 31:45-57. Franceschi, R. T., W. M. James, and G. Zerlauth. 1985. 1α,25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line. J. Cell. Physiol. 96:191-198. Ganong, W. 1997. Hormonal control of calcium metabolism and the physiology of bone. Review of Medical Physiology (Ed. Ganong W.F.):359-371. Ganta, D. R., McCarthy M. B. and Gronowicz G. A. Ascorbic acid alters collagen integrins in bone culture. Endocrinology, 138, pp. 3606-3612. George, J. M., R. P. Carmen. 1984. Poultry products technology. Third Edition. Food products press. Pp353-385. New Yolk. Haworth Press. Gilbert, A. B. 1971. In physiology and biochemistry of domestic fowl, Vol. 3 (Ed Bell, D. J. and B. M. Freeman). P1291, Academic Press. Guillerminet, F. H. Beaupied, V. Fabien-Soule, D. Tome, C.-L. benhamou, C. Roux, and A. Blais. 2010. Hydrolyzed collagen improves bone metabolism and biomechanical parameters in ovariectomized mice: An in vitro and in vivo study. Bone 24:827-834. Harris, E. D., J. E. Blount, and R. M. Leach, Jr. 1980. Localization in eggshell membrane formation and composition. Science 208:55-56. Henry K. L. and Norman A. W. 1995.Vitamin D: Metabolism and biological actions. A syndrome Lancet. 268:431-434. Heremans, H., A. Billiau, J. Cassiman, J. C. Mulier, and P. DeSomer. 1978. In vitro cultivation of human tumor tissues II. Morphological and virological characterization of three cell lines. Oncology. 35:246-252. Huether, S. E. and K. L. McCance. 2000. Understanding Pathophysiology. Second edition. Huether, S. E., K. L. McCance. 1989. Endocrinology and metabolism clinics of north America-metabolic bone disease, part I (18):no.4. Huiying, L. I., N. Tsuneo, T. Takahiro, L. I. Jianxin, M. Tatsuro, P. J. Kumar, T. Syuichi, T. Yasuhiro, K. Shiqetoshi, and S. Hikaru. 1998. Understanding Pathophysiology. Antiosteoporotic activity of the steams of Sambucus sieboldiana. Biol Pharm Bull. 21(6):594-598, Mundy G. R. 1999. Bone remodeling and its disorders. Martin Dunitz, 2nd edition, USA. 356-372. Im, G.-I., S. A. Qureshi, J. Kenney, H. E. Rubash, and A. S. Shanbhag. 2004. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials. 25:4105-4115. John, W. G. 1980. Collagen : the anatomy of a protein. Studies in biology No.117:1-53. Kader, K. E., D. F. Holmes, J. A. 1996. Trotter and J. A. Chapman. Collagen fibril formation. Biochem J. 316 (pt 1):1-11. Karl, E. K., K. E. Kadler, D. F. Holmes, J. A. Trotter, and J. A. Chapman. 1996. Collagen fibril formation. Biochem. J.316, 1-11. Kimble, R. B., A. K. Hogasen, L. Nordsletten, A. O. Aasen, and J. A. Falch. 1995. There is no difference in spontaneous and 17 beta-estradiol-induced interleukin-1 beta release by peripheral blood mononuclear cells from nonosteoporotic women with different rates of early postmenopausal bone loss. Endocrinology. 136(7):3054-3061. Lee, C. H., A. Singla and Y. Lee. 2001. Biomedical applications of collagen. Int J Pharm. 221. 1-22. Lee, W. 1997. Skeletal tissue. Principles of anatomy and physiology (Ed. Lee Liu, S. H., R. S. Yang, R. Shaikh, and J. M. Lane. 1995. Collagen in tendon, ligament, and bone healing. Clin Orthop.318:265-278. Majeska, R. J. and G. A. Rodan. 1982. The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J. Biol. Chem. 257: 3362-3365. Manolagas, S. C., D. W. Burton, and L. J. Deftos. 1981. 1,25-dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J. Biol. Chem. 256:7115-7117. Moskowitz, R. 2000. Role of collagen hydrolysate in bone and joint disease. W. B. Saunders Company. Nesheim, M. C., R. E. Austic. and L. E. Card. 1979. Poultry production, 12th ed. P46 Lea and Febiger. Posner, A. 1987. Bone mineral and the mineralization process. Bone Mineral Research (Ed. Peck W. A.) Vol:5-65. Riggs, B. L., L. J. Melton 1992. 3rd : The prevention and treatment of osteoporosis. N Engl J. Med. 327(9):620-627. Romanoff, A. L. and A. J Romanoff. 1949. The avian egg. John Wiley and Sons, New Yolk. Shing-Chuan Shen. 2002. In vitro and in vivo inhibitory activities of rutin, wogonin, quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E2 production. European Journal of Pharmacology. 446:187-194. Sikavitsas, V. I., J. S. Temenoff, A. G. Mikos. 2001. Biomaterials and bone mechanotransduction. Biomaterials. 22:2581-2593. Simkiss, K. and T. G. Taylor. 1973. In physiology and biochemistry of domestic fowl, D. J. Bell and B. M. freeman (Editors), Vol. 3, Academic Press, New Yolk. Stein, G. S., J. B. Lian, J. L. Stein, A. J. Van Wijnen, M. Montecino. 1996. Trascriptional control of osteoblast growth and differentiation. Physiol. Rev. 76:593-629. Suguro, N., S. Horiike, Y. Masuda, M. Kunou and T. Kokubu. 2000. Bioavailability and commercial use of eggshell calcium, membrane proteins and yolk lecithin products. Page 219-220 in Egg Nutrition and Biotechnology. J. S. Sim, S. Nakai and W. Guenter, ed. CAB international, JP. Szmuckler-moncler S., Dean D. D. and Schwartz Z., Titanium surface roughness alters responsiveness of MG-63 osteoblast-like cells to 1 α,25-(OH)2D3. J. Biomed. Mater. Res., 39, pp.77-85. Takahashi K., Ghatei M. A. 1993. Presence of endothelin immunore-activity in human osteoblast cell in culture medium. The 4th international symposium on osteoporosis and consensus development conference, Hong Kong, 27 March-2April, 522. Tortora, G. J. 1999. Principles of human anatomy. Benjamin/ Cummings Science Publishing, 8th edition, USA, 547-562. U.S.D.A., Dapartment of agriculture. 1968. Eggg granding manual. U.S.D A.,Washington, D.C. Viguet-Carrin, S., P. Garnero, P. D. Delmas. 2006. The role of collagen in bone strength. Osteoporos Int. 17:319-336. Werkmeister, J. A. and J. A. M. Ramshaw. 2000. Immunology of collagen-based biomaterials. In D. L. Wise (Ed.), Biomaterials and bioengineering handbook. pp 739-759. New York. Marcel Dekker. Wong, M., M. J. C. Hendrix, K. Mark, C. Little, and R. STERN. 1984. Collagen in the egg shell membranes of the hen. Dev. Biology. 104:28-36. Yao, W.-J. and C.-C. Wu. 1999. Recent advances in bone density measurement. Show-Chwan Med. J. 1(4):179-185. Young, M. F. 2003. Bone matrix proteins: their function, regulation, and relationship to osteoporosis. Osteoporos Int. 14:S35-S42. Zheng L., C. Watson, and D. DellaPenna. 1992. Reduction to tomato polygalacturonase subunit expression affects pectin solubilization and degradation during fruit ripening.Plant Cell 6: 1623–1634. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/7014 | - |
dc.description.abstract | 全世界之液蛋廠、餐廳及蛋品加工廠,每年會產生六百五十五萬噸之廢棄蛋殼,目前廢棄蛋殼之應用,主要以作為廢棄垃圾丟棄或加入鳥禽類飼料中,添加其鈣質營養量,其利用性值得深入探討 (Suguro et al., 2000)。最早於1962,Baker及Balch發現將蛋殼溶於酸性溶液中,其粗萃取物中發現含有大量羥脯胺酸,最後鑑定確定為第I及V型膠原蛋白。而目前已有相關研究指出利用不同來源之膠原蛋白 (牛皮、雞、魚與豬) 進行水解後,進行骨質疏鬆相關之細胞與動物實驗,結果發現不論在細胞或動物實驗方面,與控制組相比皆有正面之效果。
骨質疏鬆症 (Osteoporosis) 為一種常見的全身性骨骼代謝異常的疾病,主要是因為在骨骼的代謝過程中骨形成作用與骨吸收作用之間不平衡所導致,使骨密度減少進而造成骨質中鈣質的流失,導致骨骼支撐力降低,所以骨骼容易碎裂 (Fanny et al., 2010)。 本篇研究主要探討蛋殼粉、蛋殼膜膠原蛋白水解液以及蛋黃水解液在骨母細胞上之影響,實驗材料主要利用蛋殼膜萃取膠原蛋白,而後利用1%之胃蛋白酶進行酵素水解 ; 蛋黃粉部分則利用胃蛋白酶及胰蛋白酶兩種酵素進行水解試驗,兩者試驗皆於37℃下,水解時間0-10小時。再將此三種不同水解液進行胜肽含量測試。選出最佳胜肽含量後,額外添加類骨母細胞 (MG-63) 中進行共培養。而後進行細胞增生試驗、鹼性磷酸酶活性測試、骨礦化節點分析等功能評估。 實驗結果顯示,添加於MG-63類骨母細胞進行培養後,其中以經胰蛋白酶水解6小時之蛋黃水解液以及經胃蛋白酶水解8小時之蛋殼膜膠原蛋白水解液不論在細胞增生與鹼性磷酸酶活性都有顯著差異。而在細胞增生之結果顯示,當水解液濃度高於200 μg/mL時,對於MG-63 之增生有抑制之效果。因此,不論蛋殼膜膠原蛋白水解液或蛋黃水解液與MG-63細胞進行培養時,若要有效刺激類骨母細胞生長,其濃度在0-100 μg/mL與控制組相比有顯著之效果。本實驗結果也證實經胃蛋白酶水解8小時之蛋殼膜膠原蛋白水解液與經胰蛋白酶水解6小時之蛋黃水解液在鹼性磷酸酶試驗與控制組相比有顯著之效果,其又以額外添加0.1%蛋殼粉效果更為顯著。而在茜紅素染色試驗方面,同時添加經胃蛋白酶水解8小時之蛋殼膜膠原蛋白水解液與經胰蛋白酶水解6小時與0.1%蛋殼粉之處理組時,與控制組相比其礦化效果更為顯著。因此我們可以知道就述實驗條件下,會增加骨細胞中之鹼性磷酸酶活性與骨礦化效果,進而促進類骨母細胞之生長。 綜合上述,膠原蛋白水解液對刺激類骨母細胞其生長確實有一定的效果,未來在骨骼發展及預防骨質疏鬆上深具潛力。 | zh_TW |
dc.description.abstract | Abstract
Eggshell is a major byproduct of liquid egg industry and consists of collagen I, V and X in its membrane. Some studies suggest that hydrolyzed collagen-enriched diet improves bone collagen metabolism and BMD (bone mineral density). Using osteoblast-like MG-63 cells as a model system capable of partial osteoblastic differentiation, the effect of purified collagen on growth and morphological change were examined. The objective of this study was to investigate the effect of eggshell powder, collagen hydrolysate and egg yolk hydrolysate on bone cell function. The samples were prepared by hydrolyzing eggshell membrane collagen and egg yolk using pepsin and trypsin, at 37℃ for 1 to 10 hours. The hydrolysates of eggshell membrane collagen, egg yolk and eggshell powder were co-incubated with MG-63 cells then evaluated by the assays of proliferation, osteoblast differentiation and matrix mineralization using MTT (3- (4, 5-dimethylthiazol-2-yl) -2, 5-diphenyl tetrazolium bromide), alkaline phosphatase (ALP) activity and alizarin red staining, respectively. The results obtained from MG-63 cells in vitro test demonstrated that the egg yolk hydrolyzed by trypsin for 6 hours (ET6) and the collagen hydrolyzed by pepsin for 8 hours (CP8) were able to stimulate cell growth and ALP activity. The results of MTT assay indicated that the growth of MG-63 was inhibited by the samples at concentration higher than 200 μg/ml. In contrast, the proliferation of MG-63 was only stimulated at low concentration (0-100 μg/ ml) of hydrolyzed egg yolk and collagen. The result also demonstrated that the CP8 and ET6 revealed a highest ALP activity, especially the hydrolysates of collagen and egg yolk to added 0.1% eggshell powder. Furthermore, the alizarin red staining indicated that the mineralization was slightly enhanced when stimulated by the sample prepared by incorporating ET6 within CP8 and eggshell powder. It is concluded that the ET6、CP8 and 0.1% of eggshell powder can increase significantly osteoblast activity, which acts on bone remodeling. Key Words: Osteoblast, Eggshell Membranes, Collagen Hydrolysate, Egg Yolk Hydrolysate, Eggshell Powder | en |
dc.description.provenance | Made available in DSpace on 2021-05-17T09:24:00Z (GMT). No. of bitstreams: 1 ntu-101-R99626007-1.pdf: 7001278 bytes, checksum: 1732d9e78046e242b78b008398cac706 (MD5) Previous issue date: 2012 | en |
dc.description.tableofcontents | 口試委員會審定書
誌謝 目錄 I 表目錄 IV 圖目錄 V 中文摘要 i 英文摘要 iii 壹、緒論 1 貳、文獻檢討 3 一、蛋殼 3 二、蛋殼膜 7 三、蛋黃 10 四、膠原蛋白 15 (一)、分布及來源 21 (二)、應用 21 (三)、對人體之功能 22 五、骨質疏鬆 24 (一)、骨質疏鬆症簡介 24 (二)、骨質疏鬆症之成因 28 六、目前臨床預防與治療骨質疏鬆之方法 29 (一)、鈣劑 29 (二)、賀爾蒙代替治療 (hormone replacement therapy ; HRT) 30 (三)、抑鈣素 30 (四)、活性維生素D 30 (五)、雙磷酸鹽類藥物 (bisphosphate) 31 七、骨細胞 31 (一)、骨細胞簡介 31 (二)、骨母細胞 (Osteoblast) 簡介 35 (三)、骨重塑作用 36 (四)、MG-63細胞及類骨母細胞 39 (五)、研究細胞增生之方法 39 (六)、研究骨細胞分化作用之方法 43 參、材料與方法 46 試驗設計 47 實驗方法 48 第一節 : 雞蛋殼膜之膠原蛋白萃取及分析 48 (一)、實驗流程 48 (二)、蛋殼膜之分離 48 (三)、蛋殼膜膠原蛋白之萃取 49 第二節 : 蛋殼膜膠原蛋白及蛋黃粉之水解 50 (一)、蛋殼膜膠原蛋白之水解 50 (二)、市售蛋黃粉之水解 50 (三)、胜肽類濃度測定 50 第三節 : 蛋殼膜膠原蛋白水解液、蛋黃水解液和蛋殼粉與MG-63類骨母細胞培養之功能評估 52 (一)、細胞培養 53 (二)、繼代培養 55 (三)、細胞計數 57 (四)、細胞存活率測試 57 (五)、細胞型態之觀察 58 (六)、鹼性磷酸酵素 (alkaline phosphatase ; ALP) 含量測定 58 (七)、骨礦化節點分析 59 (八)、茜素紅染色 59 (九)、統計分析 60 肆、結果與討論 61 第一節 : 蛋殼膜膠原蛋白及蛋黃水解物之製備與分析 61 (一)、蛋殼膜膠原蛋白之萃取及酵素水解過程之變化 61 (二)、胜肽含量 64 第二節 : 蛋殼膜膠原蛋白水解液、蛋黃水解液和蛋殼粉與MG-63類骨母細胞培養之功能評估 67 (一)、細胞存活率測試 67 (二)、細胞型態之觀察 75 (三)、鹼性磷酸酵素 (alkaline phosphatase ; ALP) 活性測定 78 (四)、骨礦化節點分析 84 (五)、茜素紅染色 86 (六)、未來展望 89 伍、結論 90 陸、參考文獻 91 柒、作者小傳 98 | |
dc.language.iso | zh-TW | |
dc.title | 蛋殼膜膠原蛋白水解液、蛋黃水解液及蛋殼粉對預防骨質疏鬆機能性之評估 | zh_TW |
dc.title | Evaluation of functional properties of egg-derived products on bone cell function | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 黃英豪,陳億乘,林詠凱 | |
dc.subject.keyword | 骨母細胞,蛋殼膜,膠原蛋白水解液,蛋黃水解液,蛋殼粉, | zh_TW |
dc.subject.keyword | Osteoblast,Eggshell Membranes,Collagen Hydrolysate,Egg Yolk Hydrolysate,Eggshell Powder, | en |
dc.relation.page | 98 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2012-08-20 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 動物科學技術學研究所 | zh_TW |
顯示於系所單位: | 動物科學技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-101-1.pdf | 6.84 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。